BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38167430)

  • 21. High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapy.
    Ost P; Cozzarini C; De Meerleer G; Fiorino C; De Potter B; Briganti A; Nagler EV; Montorsi F; Fonteyne V; Di Muzio N
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):960-5. PubMed ID: 22172901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
    Viani GA; Hamamura AC; Correa AC; de Arruda FT
    Int Braz J Urol; 2019; 45(2):237-245. PubMed ID: 30676298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study.
    Siegmann A; Bottke D; Faehndrich J; Lohm G; Miller K; Bartkowiak D; Wiegel T; Hinkelbein W
    Strahlenther Onkol; 2011 Aug; 187(8):467-72. PubMed ID: 21786112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10.
    Ghadjar P; Hayoz S; Bernhard J; Zwahlen DR; Hölscher T; Gut P; Guckenberger M; Hildebrandt G; Müller AC; Plasswilm L; Papachristofilou A; Stalder L; Biaggi-Rudolf C; Sumila M; Kranzbühler H; Najafi Y; Ost P; Azinwi NC; Reuter C; Bodis S; Kaouthar K; Wust P; Thalmann GN; Aebersold DM
    J Clin Oncol; 2015 Dec; 33(35):4158-66. PubMed ID: 26527774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moderate hypofractionation for salvage radiotherapy (HYPO-SRT) in patients with biochemical recurrence after prostatectomy: A cohort study with meta-analysis.
    Viani GA; Gouveia AG; Leite ETT; Moraes FY
    Radiother Oncol; 2022 Jun; 171():7-13. PubMed ID: 35288228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.
    Ying J; Wang CJ; Yan J; Liauw SL; Straka C; Pistenmaa D; Xie XJ; Lotan Y; Roehrborn C; Kim DN
    Am J Clin Oncol; 2017 Dec; 40(6):612-620. PubMed ID: 26165416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing biochemical recurrence in patients who have received salvage radiotherapy after radical prostatectomy: a systematic review and meta-analysis.
    Jia ZW; Chang K; Dai B; Kong YY; Wang Y; Qu YY; Zhu YP; Ye DW
    Asian J Androl; 2017; 19(4):493-499. PubMed ID: 27241314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage radiation therapy for prostate cancer patients after prostatectomy.
    Mima T; Ohori M; Hirasawa Y; Mikami R; Arai A; Hashimoto T; Satake N; Gondo T; Nakagami Y; Namiki K; Tokuuye K; Ohno Y
    Jpn J Clin Oncol; 2019 Mar; 49(3):281-286. PubMed ID: 30608594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
    Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.
    Kupelian PA; Potters L; Khuntia D; Ciezki JP; Reddy CA; Reuther AM; Carlson TP; Klein EA
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):25-33. PubMed ID: 14697417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy.
    Rogowski P; Trapp C; von Bestenbostel R; Eze C; Ganswindt U; Li M; Unterrainer M; Zacherl MJ; Ilhan H; Beyer L; Kretschmer A; Bartenstein P; Stief C; Belka C; Schmidt-Hegemann NS
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1417-1428. PubMed ID: 34628521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
    Johnson SB; Hamstra DA; Jackson WC; Zhou J; Foster B; Foster C; Song Y; Li D; Palapattu GS; Kunju L; Mehra R; Sandler H; Feng FY
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):275-81. PubMed ID: 23886418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling.
    Ohri N; Dicker AP; Trabulsi EJ; Showalter TN
    Eur J Cancer; 2012 Apr; 48(6):837-44. PubMed ID: 21945099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: Its impact and optimal candidate.
    Tomita N; Uchiyama K; Mizuno T; Imai M; Sugie C; Ayakawa S; Niwa M; Matsui T; Otsuka S; Manabe Y; Nomura K; Kondo T; Kosaki K; Miyakawa A; Miyamoto A; Takemoto S; Yasui T; Shibamoto Y
    Asia Pac J Clin Oncol; 2020 Aug; 16(4):273-279. PubMed ID: 32519506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.
    Cozzarini C; Montorsi F; Fiorino C; Alongi F; Bolognesi A; Da Pozzo LF; Guazzoni G; Freschi M; Roscigno M; Scattoni V; Rigatti P; Di Muzio N
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):966-74. PubMed ID: 19619960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The timing of salvage radiotherapy after radical prostatectomy: a systematic review.
    King CR
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):104-11. PubMed ID: 22795730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomy.
    Vogel MME; Kessel KA; Schiller K; Devecka M; Gschwend JE; Weichert W; Wilkens JJ; Combs SE
    Radiat Oncol; 2019 Nov; 14(1):198. PubMed ID: 31711524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy.
    Tilki D; Preisser F; Tennstedt P; Tober P; Mandel P; Schlomm T; Steuber T; Huland H; Schwarz R; Petersen C; Graefen M; Ahyai S
    BJU Int; 2017 May; 119(5):717-723. PubMed ID: 27743493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.